-
Tirzepatide
API’s Name Indication Innovator Patent Expiry Date(The U.S) Tirzepatide Type 2 diabetes, lose weight Eli Lilly Jan.05,2036 -
Thalidomide
API’s Name Indication Specification US DMF EU DMF CEP Thalidomide Oncology drug USP/EP -
Ticagrelor
API’s Name Indication Specification US DMF EU DMF CEP Ticagrelor Anticoagulant In-House 28984 √ -
Tofacitnib Citrate
API’s Name Indication Specification US DMF EU DMF CEP Tofacitnib Citrate Rheumatoid arthritis In-House